FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina™ in the Treatment of Diabetic Macular Edema (DME)
June 22, 2015
Ampio Pharmaceuticals Provides Information on the Formation and Significance of Aytu BioScience to Ampio Shareholders
June 16, 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – AMPE
June 13, 2015
TRADING ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important July 7, 2015 Deadline - AMPE
June 12, 2015
Ampio Pharmaceuticals Reports the Synergistic Effects of Ampion™ in the Treatment of Osteoarthritis of the Knee in Three Peer-reviewed Publications
June 09, 2015
Ampio Pharmaceuticals Announces Update of STRIDE Study for the Investigation of Pain Associated with Osteoarthritis
June 04, 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AMPE
May 29, 2015
Ampio Pharmaceuticals Announces Positive Study Results on Optina™ for the Treatment of Diabetic Macular Edema
May 21, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here